Comparison 2. UACE plus MTX versus ultrasonography‐guided local MTX injection.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
2.1 Treatment success after initial treatment | 1 | 45 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.95 [0.56, 1.60] |
2.2 Time to normalize β‐hCG | 1 | 45 | Mean Difference (IV, Fixed, 95% CI) | 1.50 [‐3.16, 6.16] |
2.3 Adverse effects (overall) | 1 | 45 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.88 [0.40, 1.92] |